University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy

Not Applicable

Withdrawn

Conditions: Cognitive Impairments
RRSO

Interventions: Drug: Placebo
Drug: lisdexamfetamine

First Posted Date: 2013-11-18

Last Posted Date: 2017-09-18

Lead Sponsor: University of Pennsylvania

Registration Number: NCT01986777

Locations: 🇺🇸
Penn Center for Women's Behavioral Wellness, Philadelphia, Pennsylvania, United States

Effects of Niacin On Fatty Acid Trapping

Phase 1

Completed

Conditions: Dyslipidemia

Interventions: Other: Placebo Oral Fat Challenge
Drug: IR Niacin Oral Fat Challenge
Drug: ER Niacin Oral Fat Challenge

First Posted Date: 2013-11-14

Last Posted Date: 2020-07-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 26

Registration Number: NCT01984073

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Presbyterian Hospital, Philadelphia, Pennsylvania, United States

Take Charge of Your Diabetes

Not Applicable

Completed

Conditions: Diabetes
Hypertension

First Posted Date: 2013-11-06

Last Posted Date: 2015-12-09

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 136

Registration Number: NCT01977495

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women

Phase 4

Completed

Conditions: Menopause
Brain Activity
Cognition

Interventions: Other: Placebo
Drug: Lisdexamfetamine

First Posted Date: 2013-11-06

Last Posted Date: 2018-07-27

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 18

Registration Number: NCT01977625

Locations: 🇺🇸
University of Pennsylvania, Penn Center for Womens Behavioral Wellness, Philadelphia, Pennsylvania, United States

Fetal Thymus Involution as a Predictor of Adverse Neonatal Outcomes

Completed

Conditions: Women Admitted to Labor and Delivery for the Management of Preterm Labor and/or Preterm Premature Rupture of Membranes (PPROM)

First Posted Date: 2013-11-05

Last Posted Date: 2017-03-30

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 125

Registration Number: NCT01975792

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Sugar Text: A Randomized Controlled Trial of a Text Message Intervention for Women With Diabetes in Pregnancy

Not Applicable

Completed

Conditions: Diabetes in Pregnancy
Gestational Diabetes
Texting Interventions

Interventions: Behavioral: Text Message Intervention

First Posted Date: 2013-10-31

Last Posted Date: 2015-02-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 30

Registration Number: NCT01973374

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

A Patient Advocate to Improve Real-world Asthma Management for Inner City Adults

Not Applicable

Completed

Conditions: Asthma
Communication

Interventions: Behavioral: Patient Advocate
Behavioral: Usual Care

First Posted Date: 2013-10-30

Last Posted Date: 2022-09-13

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 312

Registration Number: NCT01972308

Locations: 🇺🇸
University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States

Bolus of Saline in Stroke

Phase 2

Completed

Conditions: Ischemic Stroke

Interventions: Other: Normal saline

First Posted Date: 2013-10-29

Last Posted Date: 2019-12-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 81

Registration Number: NCT01971463

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Predictors of Post Operative Morbidity in Older Women With Pelvic Organ Prolapse

Completed

Conditions: Pelvic Organ Prolapse

First Posted Date: 2013-10-22

Last Posted Date: 2014-12-10

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 132

Registration Number: NCT01967446

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery

Early Phase 1

Terminated

Conditions: Aortic Disease

Interventions: Drug: epsilon-aminocaproic acid (EACA)

First Posted Date: 2013-10-18

Last Posted Date: 2019-05-02

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 8

Registration Number: NCT01965730

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy